93 Additionally, tirzepatide, a dual GIP/GLP-1 receptor agonist, has gained prominence following USFDA approval in 2023 for weight management in adults with obesity or overweight and has demonstrated robust efficacy in RCTs
The test reveals predispositions in GLP-1 receptor and metabolic pathways, helping inform long-term therapy discussions with your provider
You can also sign up for automatic refills on eligible prescriptions to ensure your medicine will always be on hand
Compounded semaglutide is a form of the diabetes medication semaglutide that is custom-prepared by our compounding pharmacy(s)
If your Aetna plan requires step therapy, your healthcare provider may need to document and attest that you have tried metformin for one month and it didnt work well for you, whether that was due to lack of effectiveness, an allergy, side effects or interactions